Literature DB >> 15042236

Can measles be eradicated globally?

Ciro A de Quadros1.   

Abstract

Measles is one of the most infectious diseases. Before measles vaccine was introduced, nearly everyone contracted the disease at some point in childhood. By the late 1980s, most countries had incorporated measles vaccine into their routine immunization programmes. Globally, about 800 000 children nevertheless still die from measles annually, half of them in Africa. Eradicating measles would therefore play an important role in improving children's survival. The 24th Pan American Sanitary Conference in 1994 established a goal of eradicating measles from the Americas. Progress to date has been remarkable and the disease is no longer endemic in the Americas, with most countries having documented interruption of transmission. As of November 2003, 12 months had elapsed since the last indigenous case was detected in Venezuela. This experience shows that measles transmission can be interrupted, and that this can be sustained over a long period of time. Global eradication is feasible if an appropriate strategy is implemented. Even under a new paradigm in which immunization is not discontinued after measles is eradicated, eradication will be a good investment to avoid expensive epidemics and save the lives of almost one million children annually. A world free of measles by 2015 is not a dream.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042236      PMCID: PMC2585902     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  Investigation of a measles outbreak in Cordillera, Northern Philippines, 2013.

Authors:  Paola Katrina Ching; Ma Justina Zapanta; Vikki Carr de Los Reyes; Enrique Tayag; Rio Magpantay
Journal:  Western Pac Surveill Response J       Date:  2016-07-11

2.  Elimination Phase of Measles: an Epidemiological Survey in Gonabad (Iran) during 2006-2010.

Authors:  Ramezani A Hamed; Atarodi B Alireza; Mahdi Moshki
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

3.  The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Amabelia Rodrigues; Christine S Benn; Hilton Whittle
Journal:  BMJ Open       Date:  2012-07-19       Impact factor: 2.692

Review 4.  The role of research in viral disease eradication and elimination programs: lessons for malaria eradication.

Authors:  Joel G Breman; Ciro A de Quadros; Walter R Dowdle; William H Foege; Donald A Henderson; T Jacob John; Myron M Levine
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

5.  The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau.

Authors:  S M Rasmussen; S Biering-Sørensen; S Byberg; A Andersen; M Bjerregaard-Andersen; A Rodrigues; C S Benn; C L Martins; P Aaby
Journal:  BMC Pediatr       Date:  2016-12-03       Impact factor: 2.125

6.  Challenges to global measles eradication: is it all in the timing?

Authors:  Robert Davis; William Baguma Mbabazi
Journal:  Pan Afr Med J       Date:  2017-06-21

7.  Investigation of Measles Outbreak among Thai and Migrant Workers in Two Factories in Nakhon Pathom, Thailand, 2019.

Authors:  Suphanat Wongsanuphat; Phanthanee Thitichai; Rungrot Jaiyong; Patchanee Plernprom; Kanthika Thintip; Charuttaporn Jitpeera; Rapeepong Suphanchaimat
Journal:  Int J Environ Res Public Health       Date:  2020-06-27       Impact factor: 3.390

Review 8.  Global measles elimination.

Authors:  William J Moss; Diane E Griffin
Journal:  Nat Rev Microbiol       Date:  2006-11-06       Impact factor: 60.633

9.  A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions.

Authors:  Cesario L Martins; Christine S Benn; Andreas Andersen; Carlito Balé; Frederik Schaltz-Buchholzer; Vu An Do; Amabelia Rodrigues; Peter Aaby; Henrik Ravn; Hilton Whittle; May-Lill Garly
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

Review 10.  Measles control and the prospect of eradication.

Authors:  W J Moss
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.